A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by Yale University.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Yale University
Collaborators:
PhytoCeutica
National Comprehensive Cancer Network
Hoffmann-La Roche
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT00411762
First received: December 13, 2006
Last updated: April 28, 2009
Last verified: April 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2010 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |